Squamous Cell Carcinoma of Head and Neck Clinical Trials in Detroit, Michigan

4 studies are recruiting for squamous cell carcinoma of head and neck in Detroit, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

    The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent/metastatic head and neck …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Locations
    56 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06385080 on ClinicalTrials.gov

  2. A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

    The purpose of this study is to compare anti-tumor activity of amivantamab in addition to pembrolizumab and carboplatin versus pembrolizumab, 5-fluorouracil (FU), and platinum therapy (carboplatin or cisplatin) in participants with refractory/metastatic (R/M) head and neck squamous cell carcinoma (…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Locations
    201 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT07276399 on ClinicalTrials.gov

  3. A Study of DM005 in Patients With Advanced Solid Tumors

    The goal of this clinical trial is to find out about the safety, efficacy, and tolerability of DM005 for patients with the advanced solid tumors. DM005 is an experimental drug which is not approved by health authorities for the treatment of advanced solid tumors. For each participant, there will be…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Henry Ford Cancer Institute, Detroit, Michigan
    Locations
    6 in total
    Run by
    Doma Biopharmaceutical（Suzhou）Co., Ltd.

    See if you can join NCT06515990 on ClinicalTrials.gov

  4. A Beta-only IL-2 ImmunoTherapY Study

    This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor activity of MDNA11 alone or in combination with a checkpoint inhibitor in patients with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Karmanos Cancer Institute, Detroit, Michigan
    Locations
    27 in total
    Run by
    Medicenna Therapeutics, Inc.

    See if you can join NCT05086692 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.